Literature DB >> 7869611

Inhibitory action of a (1-->6)-beta-D-glucan-protein complex (F III-2-b) isolated from Agaricus blazei Murill ("himematsutake") on Meth A fibrosarcoma-bearing mice and its antitumor mechanism.

H Itoh1, H Ito, H Amano, H Noda.   

Abstract

The effects of F III-2-b (Agaricus blazei Murill polysaccharide) with or without 5-fluorouracil (5-FU) on immune responses were investigated in Meth A tumor-bearing and normal mice. The i.p. administration of F III-2-b (10 mg/kg/day x 30) moderately inhibited the growth of Meth A tumor cells implanted s.c. in mice. Development of implanted tumors was strongly inhibited by the combination of F III-2-b and 5-FU. The picryl chloride-induced delayed type hypersensitivity (PC-DTH) response in mice was depressed after the implantation of tumor and treatment with 5-FU. F III-2-b restored the suppression of PC-DTH by 5-FU, but did not increase the PC-DTH of normal mice. F III-2-b not only enhanced the degree of spleen cell-mediated sheep red blood cells (SRBC) hemolysis (quantitative hemolysis of SRBC), the indexes of the spleen and thymus, and the number of spleen cells but also restored the suppressive effect of 5-FU. In the group receiving F III-2-b, the percentages of splenic Thy1.2-, L3T4- and asialo GM1-positive cells were significantly increased as compared with the tumor-bearing mice treated with saline. Furthermore, the L3T4+/Lyt2+ ratio showed a tendency to increase, and the Lyt2+ ratio was markedly decreased. These results suggest that the antitumor effect of F III-2-b may be correlated with the changing pattern of the Thy1.2-, L3T4- and asialo GM1-positive cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7869611     DOI: 10.1254/jjp.66.265

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  22 in total

1.  An extract of the medicinal mushroom Agaricus blazei Murill differentially stimulates production of pro-inflammatory cytokines in human monocytes and human vein endothelial cells in vitro.

Authors:  Soosaipillai Bernardshaw; Geir Hetland; Linda Kathrine Ellertsen; Anne Merete Aaland Tryggestad; Egil Johnson
Journal:  Inflammation       Date:  2005-12       Impact factor: 4.092

2.  Suppressing effects of daily oral supplementation of beta-glucan extracted from Agaricus blazei Murill on spontaneous and peritoneal disseminated metastasis in mouse model.

Authors:  Hiroshi Kobayashi; Ryuji Yoshida; Yasufumi Kanada; Yoichi Fukuda; Tatsuo Yagyu; Kiyokazu Inagaki; Toshiharu Kondo; Noriyuki Kurita; Mika Suzuki; Naohiro Kanayama; Toshihiko Terao
Journal:  J Cancer Res Clin Oncol       Date:  2005-05-10       Impact factor: 4.553

3.  Agaricus blazei Murill as an efficient hepatoprotective and antioxidant agent against CCl4-induced liver injury in rats.

Authors:  Abeer M Al-Dbass; Sooad K Al-Daihan; Ramesa Shafi Bhat
Journal:  Saudi J Biol Sci       Date:  2012-04-01       Impact factor: 4.219

4.  Agaricus subrufescens: A review.

Authors:  Komsit Wisitrassameewong; Samantha C Karunarathna; Naritsada Thongklang; Ruilin Zhao; Philippe Callac; Serge Moukha; Cyril Férandon; Ekachai Chukeatirote; Kevin D Hyde
Journal:  Saudi J Biol Sci       Date:  2012-01-14       Impact factor: 4.219

5.  In vivo growth-inhibition of Sarcoma 180 by an alpha-(1-->4)-glucan-beta-(1-->6)-glucan-protein complex polysaccharide obtained from Agaricus blazei Murill.

Authors:  Maria Leônia Costa Gonzaga; Daniel Pereira Bezerra; Ana Paula Negreiros Nunes Alves; Nylane Maria Nunes de Alencar; Rodney de Oliveira Mesquita; Michael Will Lima; Sandra de Aguiar Soares; Cláudia Pessoa; Manoel Odorico de Moraes; Letícia Veras Costa-Lotufo
Journal:  J Nat Med       Date:  2008-08-23       Impact factor: 2.343

6.  Interleukin-12- and interferon-gamma-mediated natural killer cell activation by Agaricus blazei Murill.

Authors:  Eri Yuminamochi; Taisuke Koike; Kazuyoshi Takeda; Isao Horiuchi; Ko Okumura
Journal:  Immunology       Date:  2007-03-07       Impact factor: 7.397

7.  Immunomodulating compounds in Basidiomycetes.

Authors:  Masashi Mizuno; Yosuke Nishitani
Journal:  J Clin Biochem Nutr       Date:  2013-04-19       Impact factor: 3.114

8.  Oral Treatment with Extract of Agaricus blazei Murill Enhanced Th1 Response through Intestinal Epithelial Cells and Suppressed OVA-Sensitized Allergy in Mice.

Authors:  Go Bouike; Yosuke Nishitani; Hideyuki Shiomi; Masaru Yoshida; Takeshi Azuma; Takashi Hashimoto; Kazuki Kanazawa; Masashi Mizuno
Journal:  Evid Based Complement Alternat Med       Date:  2010-09-26       Impact factor: 2.629

9.  The Mushroom Agaricus blazei Murill Elicits Medicinal Effects on Tumor, Infection, Allergy, and Inflammation through Its Modulation of Innate Immunity and Amelioration of Th1/Th2 Imbalance and Inflammation.

Authors:  Geir Hetland; Egil Johnson; Torstein Lyberg; Gunnar Kvalheim
Journal:  Adv Pharmacol Sci       Date:  2011-09-06

10.  The anti-tumorigenic mushroom Agaricus blazei Murill enhances IL-1β production and activates the NLRP3 inflammasome in human macrophages.

Authors:  Tsung-Teng Huang; David M Ojcius; John D Young; Yi-Hui Wu; Yun-Fei Ko; Tsui-Yin Wong; Cheng-Yeu Wu; Chia-Chen Lu; Hsin-Chih Lai
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.